COM:TELIXPHARMA
Telix Pharmaceuticals Limited
- Stock
Last Close
22.96
21/11 05:10
Market Cap
6.49B
Beta: -
Volume Today
1.07M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
revenue | 195.14K - | 3.48M 1,685.88% | 5.21M 49.58% | 4.90M 6.04% | 155.98M 3,084.65% | 496.66M 218.40% | ||||
cost of revenue | 3.79K - | 15.36M - | 22.09M 43.82% | 2.55M 88.47% | 61.56M 2,315.86% | 188.16M 205.67% | ||||
gross profit | -3.79K - | 195.14K 5,244.79% | -11.88M 6,185.31% | -16.88M 42.12% | 2.35M 113.92% | 94.43M 3,918.21% | 308.50M 226.71% | |||
selling and marketing expenses | 213.76K - | 577.95K 170.37% | 312K 46.02% | 1.20M 285.26% | 5.89M 390.10% | 16.19M 174.78% | 54.87M 238.96% | |||
general and administrative expenses | 54K - | 20K 62.96% | 2.46M 12,187.48% | 8.50M 245.87% | 6.51M 23.36% | 7.71M 18.41% | 34.92M 352.73% | 77.32M 121.42% | 78.98M 2.16% | |
selling general and administrative expenses | 54K - | 20K 62.96% | 2.67M 13,256.31% | 9.08M 239.83% | 7.22M 20.48% | 9.29M 28.70% | 40.81M 339.24% | 93.50M 129.12% | 133.85M 43.15% | |
research and development expenses | 62K - | 10K 83.87% | 2.98M 29,670.62% | 18.69M 527.87% | 21.16M 13.21% | 23.09M 9.09% | 34.13M 47.87% | 57.86M 69.49% | 128.84M 122.69% | |
other expenses | 112.64K - | 11.63M 10,224.64% | 11.44M 1.59% | 2.96M 74.14% | 26.20M 785.60% | 38.08M 45.33% | -29.34M 177.03% | |||
cost and expenses | 116K - | 30K 74.14% | 6.52M 21,643.75% | 27.85M 326.93% | 43.74M 57.06% | 54.47M 24.52% | 103.70M 90.39% | 251M 142.05% | 457.42M 82.24% | |
operating expenses | 116K - | 30K 74.14% | 6.52M 21,643.75% | 27.85M 326.93% | 28.38M 1.91% | 32.38M 14.08% | 101.15M 212.42% | 189.44M 87.29% | 269.27M 42.13% | |
interest expense | 9.40K - | 29.02K 208.67% | 2.41M 8,198.30% | 1.18M 51.20% | 5.22M 344.09% | 6.42M 22.96% | 13.14M 104.74% | |||
ebitda | -16K - | -14K 12.50% | -6.36M 45,356.58% | -15.68M 146.36% | -36.02M 129.75% | -44.37M 23.18% | -70.07M 57.93% | -86.83M 23.91% | 23.77M 127.38% | |
operating income | -116K - | -30K 74.14% | -6.37M 21,125.71% | -15.68M 146.32% | -40.26M 156.65% | -49.25M 22.35% | -75.25M 52.78% | -92.21M 22.54% | 17.03M 118.47% | |
depreciation and amortization | 116K - | 30K 74.14% | 3.79K 87.36% | 6.97K 83.71% | 4.24M 60,692.19% | 4.88M 15.25% | 5.17M 5.98% | 5.38M 3.96% | 6.74M 25.36% | |
total other income expenses net | -16K - | -14K 12.50% | 112.64K 904.55% | 11.63M 10,224.64% | -2.56M 122.00% | -11M 329.86% | -5.22M 52.56% | -6.42M 22.96% | -30.14M 369.75% | |
income before tax | -132K - | -44K 66.67% | -6.38M 14,393.44% | -15.71M 146.41% | -42.81M 172.47% | -60.25M 40.73% | -80.47M 33.55% | -98.62M 22.57% | 3.09M 103.13% | |
income tax expense | -16K - | -14K 12.50% | 9.40K 167.15% | -1.88M 20,141.14% | -14.95M 693.39% | -15.37M 2.80% | 45K 100.29% | 5.46M 12,026.67% | -2.12M 138.92% | |
net income | -132K - | -44K 66.67% | -6.38M 14,393.44% | -13.83M 116.87% | -27.87M 101.50% | -44.89M 61.08% | -80.51M 79.36% | -104.08M 29.27% | 5.21M 105.01% | |
weighted average shs out | 127.99M - | 202.12M 57.92% | 233.44M 15.49% | 257.27M 10.21% | 282.21M 9.69% | 310.64M 10.08% | 319.18M 2.75% | |||
weighted average shs out dil | 127.99M - | 202.12M 57.92% | 233.44M 15.49% | 257.27M 10.21% | 282.21M 9.69% | 310.64M 10.08% | 319.18M 2.75% | |||
eps | 0 - | 0 | -0.05 Infinity% | -0.07 37.35% | -0.12 75.44% | -0.17 41.67% | -0.29 70.59% | -0.34 17.24% | 0.02 104.74% | |
epsdiluted | 0 - | 0 | -0.05 Infinity% | -0.07 37.35% | -0.12 75.44% | -0.17 41.67% | -0.29 70.59% | -0.34 17.24% | 0.02 104.74% |
All numbers in (except ratios and percentages)